Onko-Gene

Critical literature watch in the molecular oncology of solid tumors

FREN

Tumor type

Head and Neck Squamous Cell Carcinoma

OncoTree code HNSC · 4 articles

Clinical · Molecular biology · Bioinfo & AI

Whole-Genome HPV Liquid Biopsy for HPV-Associated Cancer Detection and Viral Physical State Classification

Fisch AS, Abruzzo AR, Eldfors S, et al.

Clinical cancer research

This study evaluates HPV-DeepSeek, a whole-genome sequencing assay analyzing circulating tumor HPV DNA (ctHPVDNA), coupled with the novel computational classifier HPV-SIGNAL across 235 HPV-positive cancers representing 9 anatomic sites. The assay demonstrated 99% diagnostic sensitivity and specificity while identifying four distinct viral physical states in plasma: episomal-only, episomal-rearranged, integrated-mixed, and integrated-clonal. Patients with circulating integrated viral states had significantly worse progression-free and overall survival compared to those with episomal forms. Consequently, this non-invasive approach establishes plasma-based HPV physical state classification as a potent prognostic tool at initial cancer diagnosis.

Clinical

Exploring spatial heterogeneity of PD-L1 and c-MET expression in oral squamous cell carcinoma

Busse C, Hörner M, Saravi B, et al.

Oral and maxillofacial surgery

This retrospective study investigated the spatial heterogeneity of PD-L1 and c-MET expression in oral squamous cell carcinoma (OSCC) by comparing primary tumors and matched lymph node metastases. Findings revealed that both PD-L1 and c-MET were frequently expressed in primary tumors but at significantly lower levels in corresponding lymph node metastases. A substantial discordance in PD-L1 CPS status was observed between the two tumor compartments, potentially impacting biomarker classification. While higher PD-L1 expression in primary tumors was associated with nodal metastasis, no significant correlation was found between PD-L1 and c-MET. These results highlight the critical role of spatial heterogeneity in biomarker assessment for OSCC.

Bioinfo & AI · Molecular biology · Clinical

Integrative cfDNA profiling from low-pass whole-genome sequencing enables tissue-of-origin prediction in cancer

Zhang Y, Liu L, Bao H, et al.

Molecular biomedicine

This study introduces a stacked ensemble machine learning classifier designed to predict the tissue of origin for cancers using circulating tumor DNA (ctDNA). The model integrates 11 multidimensional ctDNA features, encompassing genomic, fragmentomic, methylation/repeat, and microbial signals, derived from low-pass whole-genome sequencing. It demonstrated robust performance, achieving top-1 and top-2 accuracies of 80% and 90% in an independent validation cohort of 1,221 samples. The classifier proved effective even with low tumor fractions and successfully identified the primary site in 73.3% of cancers of unknown primary (CUP) cases. This non-invasive approach holds significant potential for guiding clinical decision-making.

Clinical · Molecular biology · Bioinfo & AI

Genome-wide variation in cell-free DNA end-motif entropy predicts immunotherapy response in head and neck cancer

Bandaru R, Fu H, Zheng H, et al.

The Journal of clinical investigation

A novel study developed a non-invasive biomarker, the regional motif diversity score (rMDS), based on whole-genome sequencing of plasma cell-free DNA (cfDNA). This biomarker predicts immunotherapy response in patients with head and neck squamous cell carcinoma (HNSCC). The rMDS demonstrated superior performance compared to existing metrics in distinguishing responders from non-responders to pembrolizumab. Longitudinal rMDS changes were associated with genomic regions linked to immunity and keratinization, suggesting a connection to telomere biology. An rMDS-based classifier achieved a high AUC (0.89-0.99) and was associated with improved disease-free survival.